- Alignment Healthcare : Cowen initiates coverage with outperform rating, $24 price target
- Amedisys : Cowen initiates with market perform rating, $195 price target
- Bright Health : Cowen starts coverage with outperform rating, $14 price target
- Cigna : Cowen downgrades to market perform from outperform, sets $235 price target
- Colfax: Goldman Sachs downgrades to neutral from buy. PT up 8.7% to $51
- Dada Nexus : Goldman Sachs adjusts price target for dada nexus to $42 from $46, maintains buy rating
- Devon Energy : Goldman Sachs removes Devon Energy from Conviction-Buy List, maintains Buy rating
- EasyJet: Barclays remains Neutral. The target price is now set at GBp 685 as compared to GBp 940 previously.
- Facebook : HSBC adjusts price target to $300 from $275, maintains reduce rating
- Global Payments : Morgan Stanley adjusts price target to $185 from $219, maintains equal-weight rating
- Humana : Cowen upgrades to outperform from market perform, sets $479 price target
- Intapp : Credit Suisse adjusts price target to $45 from $38, keeps outperform rating
- International Consolidated Airlines Group: Credit Suisse is positive on the stock with a Buy rating. The target price is reduced from GBp 256 to GBp 195.
- Iveric bio: Stifel initiated coverage of Iveric bio Inc. with a recommendation of buy. PT set to $22
- LHC : Cowen starts coverage with Outperform rating, $209 Price Target
- LifeStance Health : Cowen initiates coverage with Outperform rating, $18 Price Target
- Lululemon Athletica : Wedbush hikes price target to $340 from $300
- Sunrun : Needham initiates coverage with buy rating
- Walt Disney : Wolfe Research adjusts pt to $209 from $212, maintains outperform rating